FDA
FDA Updates COVID Shot Labels Over Rare Heart Risk
The FDA has required Pfizer and Moderna to expand their vaccine labels to include updated warnings about myocarditis, a rare heart inflammation linked to COVID‑19 shots. The updated warning reflects data from the 2023–2024 vaccine formulations. The updated labels now note about 8 cases of myocarditis per 1